Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance

Thalidomide and lenalidomide constitute an important part of effective myeloma therapy. Recent data from the Intergroup Francophone du Myélome, Cancer and Leukemia Group B, and Gruppo Italiano Malattie Ematologiche dell Adulto MM-015 trials suggest that lenalidomide maintenance therapy is associated...

Full description

Saved in:
Bibliographic Details
Main Authors: Usmani, Saad Z., Sexton, Rachel, Hoering, Antje, Heuck, Christoph J., Nair, Bijay, Waheed, Sarah, Al Sayed, Yazan, Chauhan, Nabeel, Ahmad, Nisar, Atrash, Shebli, Petty, Nathan, van Rhee, Frits, Crowley, John, Barlogie, Bart
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2012
Subjects:
Clinical Trials and Observations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3429303/
https://ncbi.nlm.nih.gov/pubmed/22674807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-04-421883
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items